Sclerotherapy for infantile hemangiomas (сlinico - experimental research)



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

ABSTRACT

BACKGROUND. Infantile hemangioma (IGS) is a common disease characterized by a variety of clinical forms, localization and prevalence, however, the effectiveness of treatment is low.

AIM: development of the method and algorithm of sclerotherapy of infantile hemangioma with detergents and study of its safety on morphological model.

METHODS. An investigation of the action of a detergent on an experimental model of chicken scallops and clinical observations of 23 children with infantile hemangiomas who received treatment for sclerosis were carried out.

RESULTS.  The method of introduction and algorithm for the application of sclerosis in infantile hemangiomas was developed on the basis of studying its effect on the vascular network and skin in an experiment on chicken scallops. Clinical and morphological data on the effect of large and small doses of MS on hemodynamics and skin structure of the experimental model were obtained. Calculated vascular mass ratio of infantile hemangioma in the progressive stage and model. A two-stage procedure is proposed, consisting of the successive introduction of anesthetic and sclerosant in the area of infantile hemangioma. Clinical cure was reported in 826% of patients, clinical improvement - in 17.4% of children with infantile hemangiomas.

CONCLUSION. Highly effective treatment of children with infantile hemangiomas has been developed. Experimental data allowed to evaluate the dynamics of clinical and morphological changes occurring under the action of sclerozantine and determine its optimal concentration.  The results of the study made it possible to avoid complications and cosmetic consequences of the treatment.

Full Text

Restricted Access

About the authors

Valery V. Dubensky

Tver State Medical University

Email: valerydubensky@yandex.ru
ORCID iD: 0000-0003-2674-1096
SPIN-code: 3577-7335

MD, Dr. Sci. (Med.), Professor

Russian Federation, 4 Sovetskaya street, 170000 Tver

Vladislav V. Dubensky

Tver State Medical University

Author for correspondence.
Email: dubensky.vladislav@yandex.ru
ORCID iD: 0000-0002-5583-928X
SPIN-code: 6044-8507

Head of Department, MD, Cand. Sci. (Medicine), Associate professor; 

Russian Federation, 4 Sovetskaya street, 170000 Tver

Elizaveta G. Nekrasova

Tver State Medical University

Email: nekrasova-7@mail.ru
ORCID iD: 0000-0002-2805-6749
SPIN-code: 5831-5824

MD, Cand. Sci. (Medicine), Associate professor

 

Russian Federation, 4 Sovetskaya street, 170000 Tver

References

  1. Infantile hemangioma. Clinical recommendations/ approved by the Ministry of Health of the Russian Federation ICD 10: D18.0; approval year 2023 ID: 769 URL: Infantile hemangioma> Clinical recommendations RF 2023 (Russia)> MedElement
  2. Khachatryan LA, Nikolaeva DM. Modern therapy of infantile hemangioma. Questions of hematology/oncology and immunopathology in pediatrics. 2021; 20(2): 156-167. doi: 10.24287/1726-1708-2021-20-2-156-167, EDN: TRJEQS
  3. Dubensky VV, Dubensky VV, Avtomonova AV, Shestakova VG. Structural changes of the skin under various methods of operative action. Morphology. 2014; 145(3):70, EDN: RVPKIN
  4. Dubensky VV. Modern approaches to the operative treatment of juvenile hemangioma. Saratov scientific-medical journal. 2015; 11(3): 471-476, EDN: VJUVBH
  5. Saulen NS, Esembekova AA. Application of sclerotizing therapy in congenital hemangiomas in children. The Bulletin of Surgery of Kazakhstan. 2017; 3: 48-51, EDN: SXNNWT
  6. Darrow HD. et al. Diagnosis and management of infantile Hemangioma. Pediatrics. 2015; 136 (4): 1060—1104. doi: 10.1542/peds.2015-2485
  7. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006 Sep;118(3):882-7. doi: 10.1542/peds.2006-0413. PMID: 16950977
  8. Khamitova RSH, Valeyev RL, Nazipov NG. Sclerotherapy of children’s maxillofacial area. Kazan medical journal. 1986; 67(1): 41-41. doi: 10.17816/kazmj62988
  9. Frieden IJ. Infantile hemangioma research: looking backward and forward. J Invest Dermatol. 2011; 131(12):2345-2348 doi: 10.1038/jid.2011.315
  10. Shimanko AI, Dibirov MD, Tsyranov SV, et al. Sclerotherapy in the complex treatment of chronic diseases of veins. Phlebology. 2012; 6(4): 43 – 48 url={https://api.semanticscholar.org/CorpusID:227778503 EDN: PLUNPP
  11. Dunelyan BA, Manjikian OP, Adyrkhayev ZA, et al. Combined micro-foam sclerotherapy with mini-phlebectomy as the optimal treatment for varicose enlarged effusions after endovenous laser coagulation. Ambulatory surgery. 2022; 19(2): 22 - 28. doi: 10.21518/1995-1477-2022-19-2-22-28
  12. Dubensky VV, Dubensky VV. Antiangiogenic potential of beta-adrenergic lockers in the aspect of treatment of juvenile hemangioma. Messenger of dermatology and venereology. 2019; 95(2): 29 - 41. doi: 10.25208/0042-4609-2019-95-2-29-41 EDN: MTRDAA

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.